Search Results 2191-2200 of 13064 for transexamic

  1. The Kronos Early Estrogen Prevention Study (KEEPS) - Mayo Clinic

    About this study. The purpose of this study is to demonstrate whether 4 years of menopausal hormone treatment (MHT) with estrogen initiated at, ...

  2. A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    About this study. The purpose of this study is to determine the safety, pharmacokinetics, preliminary anticancer activity, and RP2R(s) of the study ...

  3. Publications - Timothy B. Curry, M.D., Ph.D. - Mayo Clinic

    Webb KL, Pruter WW, Poole RJ, Techentin RW, Johnson CP, Regimbal RJ, Berndt KJ, Holmes DR 3rd, Haider CR, Joyner MJ, Convertino VA, Wiggins CC, Curry TB.

  4. Beraprost-314d Added-on to Tyvaso® (BEAT) - Mayo Clinic

    This is a multicenter, double-blind, randomized, placebo-controlled Phase 3 study, to assess the efficacy and safety of BPS-314d-MR when added-on to inhaled ...

  5. Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 - Mayo Clinic

    The purpose of this study is to test multiple experimental therapies simultaneously in patients with neurofibromatosis type 2 (NF2) with associated progressive ...

  6. Nicotine lozenge - Mayo Clinic

    Nicotine lozenges are tablets that contain a small amount of nicotine, which is absorbed through the lining of your mouth.

  7. A Study Evaluating Pembrolizumab and Epacadostat in Treating Participants With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma - Mayo Clinic

    The purpose of this trial is to assess how well pembrolizumab and epacadostat work in treating participants with ovarian clear cell carcinoma that has come back ...

  8. Eladocagene exuparvovec-tneq (injection route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  9. Publications - Kevin J. Renfree, M.D. - Mayo Clinic

    Hiredesai AN, Holle AM, Zhuang J, Howlett CP, Lai CH, Renfree KJ, Noland SS. Glucagon-Like Peptide-1 Receptor Agonist Therapy Associated With Fewer ...

  10. A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer - Mayo Clinic

    About this study. The purpose of this study is to learn about the effects of three study medicines (encorafenib, cetuximab, and pembrolizumab) given ...